Hematology NewsPrognostic features could improve ALL outcomesNovember 13, 2018ALLLeukemia, Myelodysplasia, Transplantation
Hematology TimesAP-1 plays key role in various AML subtypes, team saysNovember 13, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsTranscription factor plays key role in AML gene regulatory networksNovember 12, 2018AMLLeukemia, Myelodysplasia, TransplantationTranslational Research
Hematology TimesFinancial burden of blood cancers in the U.S.November 12, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaMyelodysplastic Syndrome
Hematology Times‘Compelling’ new target found for monocytic AMLNovember 11, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology Times‘Encouraging’ phase 2 results in rel/ref AMLNovember 9, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsReport details financial burden of blood cancersNovember 8, 2018Business of MedicinePractice ManagementLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLMultiple Myeloma
Hematology TimesFDA clears portable hematology analyzerNovember 8, 2018CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Hematology NewsVariant not linked to CLL in Southeast EuropeNovember 7, 2018CLLIndolent LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology TimesQuizartinib receives accelerated assessment for AMLNovember 7, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesChanges related to AML relapse may be reversibleNovember 6, 2018Leukemia, Myelodysplasia, TransplantationTransplantationAML
Hematology NewsVenetoclax/HMA combo still safe, effective for elderly with AMLNovember 5, 2018AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesFDA and EC approve pegfilgrastim biosimilarNovember 4, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Hematology NewsAML relapse after HSCT linked to potentially reversible immune changesNovember 2, 2018AMLCellular TherapyLeukemia, Myelodysplasia, Transplantation
Hematology TimesEC approves venetoclax in combo with rituximabNovember 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
